Diabetes
Data from the United States and Japan advance knowledge in diabetes research
Published in Obesity and Diabetes Week, October 9th, 2006
Study 1: Nocturnal hypoglycemia is common in type 1 diabetes, but a bedtime snack or terbutaline were not adequate treatments.
"We assessed four putative bedtime treatments in the prevention of nocturnal hypoglycemia in type 1 diabetes. Plasma glucose concentrations were measured every 15 min from 2200 h through 0700 h in 21 patients with type 1 diabetes (mean±SD HbA1C =7.1±1.0%) on five occasions with, in random sequence, bedtime (2200 h) administration of 1) no treatment, 2) a snack, 3) the snack plus the alpha-glucosidase inhibitor acarbose,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes & Obesity
Neuronal PTP1B regulates body weight, adiposity, and leptin action - Endocrinology
Appetite regulatory hormone responses to various dietary proteins differ by body mass index - Insulin Resistance
Cerebrocortical response to hyperinsulinemia is reduced in overweight humans - Obesity Pathogenesis
In obese, Tanner stage G1PH1 boys the inhibin B/FSH axis is activated early - Type 2 Diabetes
Obesity is a determinant of C-reactive protein levels and metabolic syndrome link in diabetes - Adipocytes
Sennidin stimulates glucose incorporation in rat adipocytes - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
